Anastasia Asimakopoulou

Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up

G Ntali, Anastasia Asimakopoulou, T Siamatras et al. · European Journal of Endocrinology · 2013 · 148 citations

Medicine, Endocrinology, Internal Medicine +13

Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis

Raghda Hassan, Salma N. Tammam, Sara El Safy et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2018 · 63 citations

Pharmacy, Biochemistry, Pharmaceutical Biotechnology +17

Lipocalin-2 (LCN2) regulates PLIN5 expression and intracellular lipid droplet formation in the liver

Anastasia Asimakopoulou, Erawan Borkham‐Kamphorst, Marc Henning et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2014 · 61 citations

Life Sciences, Biochemistry, Molecular Biology +14

TNF-α controls Lipocalin-2 expression in PC-3 prostate cancer cells

Sarah K. Schröder, Anastasia Asimakopoulou, Stefan Tillmann et al. · Cytokine · 2020 · 43 citations

Medicine, Molecular Biology, Oncology +11

Targeting Activated Hepatic Stellate Cells Using Collagen-Binding Chitosan Nanoparticles for siRNA Delivery to Fibrotic Livers

Menna Azzam, Sara El Safy, Sarah A. Abdelgelil et al. · Pharmaceutics · 2020 · 39 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17